Voluntary Exercise has Long-Term In Vivo Protective Effects on Osteocyte Viability and Bone Strength Following Ovariectomy Hélder FonsecaDaniel Moreira-GonçalvesJosé Alberto Duarte Original Research 18 March 2011 Pages: 443 - 454
Supplementation with Green Tea Polyphenols Improves Bone Microstructure and Quality in Aged, Orchidectomized Rats Chwan-Li ShenJay J. CaoJames K. Yeh Original Research 23 March 2011 Pages: 455 - 463
Effects of Risedronate in Runx2 Overexpressing Mice, an Animal Model for Evaluation of Treatment Effects on Bone Quality and Fractures Valerie GeoffroyEleftherios P. PaschalisMarie-Christine de Vernejoul Original Research 01 April 2011 Pages: 464 - 475
Use of Antidepressant Medications and Risk of Fracture in Older Women Susan J. DiemTerri L. Blackwellfor the Study of Osteoporotic Fractures Research Group Original Research 01 April 2011 Pages: 476 - 484
Randomized Trial of Alendronate Plus Vitamin D3 Versus Standard Care in Osteoporotic Postmenopausal Women with Vitamin D Insufficiency Stuart H. RalstonNeil BinkleyInvestigators of FOCUS-D (FOSAVANCE vs. Standard Care—Use and Study of Vitamin D) Trial Original Research 11 April 2011 Pages: 485 - 494
Sex Difference between Body Composition and Weight-Bearing Bone Mineral Density in Korean Adult Twins: Healthy Twin Study Taehun KimJoohon SungSung-Il Cho Original Research 09 April 2011 Pages: 495 - 502
Influence of Insulin-Like Growth Factor Binding Protein (IGFBP)-1 and IGFBP-3 on Bone Health: Results from the European Male Ageing Study Stephen R. PyeBader AlmusalamThe EMAS Study Group Original Research 19 April 2011 Pages: 503 - 510
Monthly Administration of a Novel PTH-Collagen Binding Domain Fusion Protein is Anabolic in Mice Tulasi PonnapakkamR. KatikaneniR. C. Gensure Original Research 22 April 2011 Pages: 511 - 520
Nonenzymatic Cross-Linking Pentosidine Increase in Bone Collagen and Are Associated with Disorders of Bone Mineralization in Dialysis Patients Jun MitomeHiroyasu YamamotoTatsuo Hosoya Original Research 17 April 2011 Pages: 521 - 529
Circulating Fibroblast Growth Factor 23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation James MahonMiriam Casey Letter to the Editor 18 March 2011 Pages: 530 - 530
Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation Geeta Hampson Letter to the Editor 31 March 2011 Pages: 531 - 531
